G6PD and prostate carcinoma: Gene expression analysis of CTCs of prostate cancer patients have revealed altered expression levels of eight metastasis-related metabolic genes, such as phosphoglycerate kinase 1 (PGK1) and glucose-6-phosphate dehydrogenase (G6PD) responsible for optimal glucose metabolism in CTCs.